TrialLeukemia research2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia.
Daniel J Deangelo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
TrialLeukemia research2014
Daniel J Deangelo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.